Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

iCo Therapeutics Inc V.ICO

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ICOTF

ICO Therapeutics, Inc. is a development stage pharmaceutical company engaged in the reprofiling and repositioning of drugs and drug candidates with a previous clinical history for new disease indications.
Price: $0.03 | Change: $0.00 | %Change: 0.00%
Volume: 40,000 | Day High/Low: 0.03/0.03 | 52 Week High/Low: 0.59/0.025
View modes: 
0 stars

Someone just scooped up a lot at 3 1/2 cents

Maybe A late afternoon run  rate and reply
0.5 stars

RE:RE:With News out

Sounds like ICO is just begging IMNP to buy them out. I've never seen one company release so much news on another company before, even if they do have a relationship. I can understand more
0 stars

Supermoney- pontificating would describe your remarks

All I would add is that we all hope for tangible news about ICO sooner, rather than later. Right? Best wishes to the sincere folks  here.  rate and reply
5 stars

RE:News of Immune Pharma management appointments

Kobedog, it seems you have no idea about what is “pumping”? In fact, we are not pumping here. We only use this forum to exchange information and thoughts regarding to the news, financials and more
1 star

News of Immune Pharma management appointments

Is hardly tangible news.  And ICO share price /volume  backs my opinion fully today. It did not even move  Immune's share price.  See what I mean ? Quit pumping based on nothing. That is my more
5 stars

RE:With News out

NEW YORK, Feb. 9, 2015 NEW YORK, Feb. 9, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: IMNP) announced the appointment Dr. Paul Nadler as acting Executive more
5 stars

Looks like bid s are increasing slowly

Bid 86 and ask 340 Time of post go go go ltx  rate and reply
3.5 stars

Stock house newsfeed

Three hours ago it was released  rate and reply
1 star

You are now on ignore Pops....

this is not the first time you post unrelated stuff it seems.  rate and reply
1 star

Exactly what news is out today?

I cannot find any.  rate and reply
5 stars

With News out

Should be seeing some movement in the afternoon  rate and reply
5 stars

Great upside potentials for your investment on ICO

Financials and MD&A as per their last quarterly report ending September 30th 2014, Current assets/Cash: $5.8 million Total Assets: $8.6 million Total Liabilities: only $2 million Common Shares: more
1 star

Some posters are mixing up ICO Therea with Immune Pharma

Get your facts straight please.  They are completely separate companies with different boards and management. At least that is what my careful DD shows. The comments are irrelevant from more
0 stars

Wrong board sorry

????????  rate and reply
0 stars

Look at the fake Bid at 0.1 c

Some people Think they are playing games  rate and reply
0 stars

RE:ICO ready to move up with Mr. Durrant.

I agree. ICO has great upside potential given millions cash in hand and excellent projects.  rate and reply
0 stars

RE:RE:ICO ready to move up with Mr. Durrant.

Here :  rate and reply
0 stars

RE:ICO ready to move up with Mr. Durrant.

Where did you saw that? from ICO website; Board Of Directors William Jarosz, JD - Chairman of the Board of Directors Richard Barker, DPhil, BA - Director Noel Hall, BSc - Director Andrew J. Rae, MBA more
5 stars

ICO ready to move up with Mr. Durrant.

Dr. Durrant is an entrepreneur, board member and former CEO/CFO and physician. His specialty is turnarounds and growth, both of large company brands and business units as well as small/medium more
0 stars

RE:RE:RE:sp settled??

Sca up 40% poor grammar  rate and reply